EVTLDecember 24, 2025 at 1:18 PM UTCTransportation

Vertical Aerospace Offers Flight Timeline Amid Persistent Financial Peril

Read source article

What happened

Vertical Aerospace has provided investors with a timeline for its critical piloted transition flight, addressing uncertainties following its recent global launch event. The company framed this transparency as an 'early Christmas present,' implying a strategic delay for advantage. However, the DeepValue report reveals that Vertical remains pre-revenue, with a £781m net loss in 2024 and negative equity of £499m, underscoring deep financial distress. Management has explicitly warned of going-concern risk and a likely minimum-cash covenant breach in Q4 2025 without new capital, estimating ~$700m in additional funding needed for 2028 certification. Thus, while the flight update marks minor technical progress, it does not mitigate the acute financial and operational risks that sustain the STRONG SELL thesis.

Implication

First, the transparency on the piloted transition flight may briefly improve sentiment around technical milestones, aligning with the DeepValue report's watch item for flight-test progress. Second, however, it does not resolve the company's precarious liquidity, with projected cash outflows and potential covenant breaches threatening near-term viability. Third, the need for ~$700m in additional capital heightens dilution risk for equity holders, compounded by Mudrick Capital's control and complex financing. Fourth, certification remains a distant, binary outcome amid industry-wide delays and competitive pressures from better-funded peers. Fifth, investors should therefore view this news as insufficient to shift the STRONG SELL stance, which hinges on securing substantial funding and achieving regulatory approval beyond incremental updates.

Thesis delta

The announcement provides incremental progress on a key certification milestone but does not alter the core investment thesis. Vertical's equity remains a high-risk option on future funding and regulatory approval, with significant downside potential from financial distress. No material shift from the STRONG SELL recommendation is warranted based on this news.

Confidence

High